
Covetrus Investor Relations Material
Latest events

Q1 2022
Covetrus
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Covetrus Inc
Access all reports
Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. The company design, manufacture, and sell pharmaceutical products for use in treating various ailments in animals such as horses, dogs and cats. Covetrus Animal Health offers a range of products for animal health markets including United States, Canada, Mexico, Brazil, Argentina and Peru. The company's products include drug therapies for cardiovascular conditions; respiratory disorders; gastrointestinal disease; reproductive disorders; urinary tract diseases; infectious diseases; cancers of the skin and internal organs; dental diseases and hoof care; neurotoxicosis in cattle (lesions); toxicosis and mycotoxicoses in ruminants (vomitoxin); preanesthetic products; antibiotics for poultry; parasiticides and antiparasiticides products for livestock; endectocides for swine and other animals.
Latest articles
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
Ticker symbol
CVET
Country
🇺🇸 United States